Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy
Soft Tissue Sarcomas (STS) are a heterogeneous and rare group of tumors. Immune cells, soluble factors, and immune checkpoints are key elements of the complex tumor microenvironment. Monitoring these elements could be used to predict the outcome of the disease, the response to therapy, and lead to t...
Main Authors: | Luana Madalena Sousa, Jani Sofia Almeida, Tânia Fortes-Andrade, Manuel Santos-Rosa, Paulo Freitas-Tavares, José Manuel Casanova, Paulo Rodrigues-Santos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3885 |
Similar Items
-
The Role of Natural Killer Cells in Soft Tissue Sarcoma: Prospects for Immunotherapy
by: Tânia Fortes-Andrade, et al.
Published: (2021-07-01) -
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
by: Markus Albertsmeier, et al.
Published: (2022-02-01) -
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond
by: Mina Fazel, et al.
Published: (2023-03-01) -
Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
by: Chuan Hu, et al.
Published: (2020-09-01) -
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy
by: Kamila Wojas-Krawczyk, et al.
Published: (2021-08-01)